These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30415126)

  • 21. Machine Learning-based Individual Assessment of Cortical Atrophy Pattern in Alzheimer's Disease Spectrum: Development of the Classifier and Longitudinal Evaluation.
    Lee JS; Kim C; Shin JH; Cho H; Shin DS; Kim N; Kim HJ; Kim Y; Lockhart SN; Na DL; Seo SW; Seong JK
    Sci Rep; 2018 Mar; 8(1):4161. PubMed ID: 29515131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortical thinning in verbal, visual, and both memory-predominant mild cognitive impairment.
    Kim MJ; Im K; Lee JM; Park A; Chin J; Kim GH; Kim JH; Roh JH; Seo SW; Na DL
    Alzheimer Dis Assoc Disord; 2011; 25(3):242-9. PubMed ID: 21865881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of hippocampal atrophy differ among Alzheimer's disease, amnestic mild cognitive impairment, and late-life depression.
    Joko T; Washizuka S; Sasayama D; Inuzuka S; Ogihara T; Yasaki T; Hagiwara T; Sugiyama N; Takahashi T; Kaneko T; Hanihara T; Amano N
    Psychogeriatrics; 2016 Nov; 16(6):355-361. PubMed ID: 26756596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid-Independent Amnestic Mild Cognitive Impairment and Serum Apolipoprotein A1 Levels.
    Choi HJ; Seo EH; Yi D; Sohn BK; Choe YM; Byun MS; Lee JM; Woo JI; Lee DY
    Am J Geriatr Psychiatry; 2016 Feb; 24(2):144-53. PubMed ID: 26238231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment.
    Ferreira D; Cavallin L; Larsson EM; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Simmons A; Wahlund LO; Westman E;
    J Intern Med; 2015 Sep; 278(3):277-90. PubMed ID: 25752192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High avidity HSV-1 antibodies correlate with absence of amnestic Mild Cognitive Impairment conversion to Alzheimer's disease.
    Agostini S; Mancuso R; Baglio F; Cabinio M; Hernis A; Costa AS; Calabrese E; Nemni R; Clerici M
    Brain Behav Immun; 2016 Nov; 58():254-260. PubMed ID: 27470229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel ThickNet features for the discrimination of amnestic MCI subtypes.
    Raamana PR; Wen W; Kochan NA; Brodaty H; Sachdev PS; Wang L; Beg MF
    Neuroimage Clin; 2014; 6():284-95. PubMed ID: 25379441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple diffusivities define white matter degeneration in amnestic mild cognitive impairment and Alzheimer's disease.
    Wang PN; Chou KH; Lirng JF; Lin KN; Chen WT; Lin CP
    J Alzheimers Dis; 2012; 30(2):423-37. PubMed ID: 22430530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hippocampal Subfield Atrophy in Multi-Domain but Not Amnestic Mild Cognitive Impairment.
    Eliassen CF; Selnes P; Selseth Almdahl I; Reinvang I; Fladby T; Hessen E
    Dement Geriatr Cogn Disord; 2015; 40(1-2):44-53. PubMed ID: 25924735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved.
    Espinosa A; Alegret M; Valero S; Vinyes-Junqué G; Hernández I; Mauleón A; Rosende-Roca M; Ruiz A; López O; Tárraga L; Boada M
    J Alzheimers Dis; 2013; 34(3):769-80. PubMed ID: 23271318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.
    Yu P; Dean RA; Hall SD; Qi Y; Sethuraman G; Willis BA; Siemers ER; Martenyi F; Tauscher JT; Schwarz AJ
    J Alzheimers Dis; 2012; 32(2):373-85. PubMed ID: 22796873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal changes of multidimensional surface features using multivariate pattern classification in amnestic mild cognitive impairment patients.
    Li S; Yuan X; Pu F; Li D; Fan Y; Wu L; Chao W; Chen N; He Y; Han Y
    J Neurosci; 2014 Aug; 34(32):10541-53. PubMed ID: 25100588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum.
    Cho H; Choi JY; Hwang MS; Kim YJ; Lee HM; Lee HS; Lee JH; Ryu YH; Lee MS; Lyoo CH
    Ann Neurol; 2016 Aug; 80(2):247-58. PubMed ID: 27323247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in functional brain activation and hippocampal volume among amnestic mild cognitive impairment subtypes.
    Li X; Zheng L; Zhang J; Zhou X; Ma C; Chen Y; Shu N; Zhang Z
    Curr Alzheimer Res; 2013 Dec; 10(10):1080-9. PubMed ID: 24156264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the Profile of Incidental Memory in Patients with Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Kontaxopoulou D; Beratis IN; Fragkiadaki S; Pavlou D; Andronas N; Yannis G; Economou A; Papanicolaou AC; Papageorgiou SG
    J Alzheimers Dis; 2018; 65(2):617-627. PubMed ID: 30056423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interaction of APOE genotype by age in amnestic mild cognitive impairment: a voxel-based morphometric study.
    Chen J; Shu H; Wang Z; Liu D; Shi Y; Zhang X; Zhang Z
    J Alzheimers Dis; 2015; 43(2):657-68. PubMed ID: 25114090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffusion tensor imaging measures of normal appearing white matter in patients who are aging, or have amnestic mild cognitive impairment, or Alzheimer's disease.
    Wang JH; Lv PY; Wang HB; Li ZL; Li N; Sun ZY; Zhao BH; Huang Y
    J Clin Neurosci; 2013 Aug; 20(8):1089-94. PubMed ID: 23787190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single- and multiple-domain amnestic mild cognitive impairment: two sides of the same coin?
    Brambati SM; Belleville S; Kergoat MJ; Chayer C; Gauthier S; Joubert S
    Dement Geriatr Cogn Disord; 2009; 28(6):541-9. PubMed ID: 20016185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal outcomes of amyloid positive versus negative amnestic mild cognitive impairments: a three-year longitudinal study.
    Ye BS; Kim HJ; Kim YJ; Jung NY; Lee JS; Lee J; Jang YK; Yang JJ; Lee JM; Vogel JW; Na DL; Seo SW
    Sci Rep; 2018 Apr; 8(1):5557. PubMed ID: 29615677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.